Jake Simson
Direktor/Vorstandsmitglied bei TYRA BIOSCIENCES, INC.
Vermögen: - $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Jake Simson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Massachusetts Institute of Technology
443
| College/University | Finance/Rental/Leasing | 443 |
The Johns Hopkins University
197
| College/University | Other Consumer Services | 197 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.
29
| Operating Division | Investment Managers | 29 |
| Public Company | Biotechnology | 23 | |
| Public Company | Biotechnology | 19 | |
18
| Subsidiary | Biotechnology | 18 |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities.
18
| Private Company | Investment Managers | 18 |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA.
7
| Holding Company | Biotechnology | 7 |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.
6
| Subsidiary | Investment Managers | 6 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL.
6
| Subsidiary | Biotechnology | 6 |
Xenikos BV
 Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands.
5
| Holding Company | Medical Specialties | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jake Simson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
| POIT BIOP | Pharmaceuticals: Major | President Director/Board Member Director/Board Member Director/Board Member | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Founder Director/Board Member Corporate Officer/Principal Director/Board Member | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | Founder President Director/Board Member Corporate Secretary | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Aliada Therapeutics, Inc.
 Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| RESEARCH ALLIANCE CORP. II | Financial Conglomerates | Chief Executive Officer Founder Director of Finance/CFO | |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Corporate Officer/Principal | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer | |
| CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| ALECTOR, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| OTONOMY | Biotechnology | Director/Board Member Chief Executive Officer | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
H.I.G. BioHealth Partners LLC
 H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Investment Managers | Private Equity Investor Private Equity Investor | |
DiCE Molecules, Inc.
 DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | Packaged Software | Director/Board Member Chief Executive Officer | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| San Diego State University | College/University | Undergraduate Degree Masters Business Admin | |
CinRx Pharma LLC
 CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director-Back Office Operation Chief Tech/Sci/R&D Officer | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Texas A&M University | College/University | Undergraduate Degree Undergraduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Superluminal Medicines Inc
 Superluminal Medicines Inc BiotechnologyHealth Technology Superluminal Medicines Inc is a generative biological and chemical company. The company is based in Boston, MA. The CEO of the company is Cony D'Cruz. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| KALA BIO, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Graduate Degree | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistik
International
| Vereinigte Staaten | 48 |
| Vereinigtes Königreich | 3 |
| Kanada | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 19 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 523 |
| Corporate Officer/Principal | 170 |
| Founder | 106 |
| Independent Dir/Board Member | 99 |
| Undergraduate Degree | 83 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert Langer | 88 |
| Nina Kjellson | 49 |
| Robert More | 42 |
| Jay Lichter | 38 |
| Joshua Resnick | 36 |
| Neil Exter | 33 |
| Peter Kolchinsky | 32 |
| Vickie Capps | 28 |
| Richard Scheller | 27 |
| Susan Hockfield | 26 |
| Jim Scopa | 26 |
| Risa Stack | 25 |
| Abbie Celniker | 23 |
| Shaan Gandhi | 22 |
| Andrew Levin | 21 |
- Börse
- Insiders
- Jake Simson
- Unternehmensverbindungen
